Frazier Life Sciences adds $1.1bn to public biotech fund, taking total commitments to $2.8bn
Tuesday, September 15, 2026 · first reported by AltAssets
Frazier Life Sciences raises $1.1bn from new and existing investors for public biotech fund; total commitments reach $2.8bn since 2021 launch.
- Fund
- Frazier Life Sciences Public Biotech Fund
- Size
- $1.1B
- Stage
- Interim close
- Asset class
- Venture
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore in Venture capital
From the same day- PSG Equity Closed PSG Europe III Above €4.4 Billion for European Software and TechHedgeCo Insights +1
- Radical Ventures announces the largest venture capital fund in Canadian historyPR Newswire +8
- Transformation Capital Closed Digital-Health Fund IV at an $850 Million Hard CapHedgeCo Insights
- Intrepid Growth Partners Closed a $525 Million Inaugural AI Growth FundHedgeCo Insights
- Crane Venture Partners raises €419 million as it expands across Europe, APAC and the USEU-Startups
- Permanent Capital sees its GTM assistance as key differentiatorVenture Capital Journal